Private company

Zogenix (United States)

Zogenix (United States) is an American pharmaceutical preparations company based in Emeryville.1 It was founded in 2006.1

Last updated Oct 20, 2026.

Overview

2006Founded1
  • IndustryPharmaceutical Preparations1
  • HeadquartersEmeryville1
  • Websitezogenix.com/c/company
  • Legal formDelaware corporation1
  • Incorporated inDE4
  • Business address5959 Horton Street, Suite 500, Emeryville, Ca 946084
  • Filer categoryLarge accelerated filer4
  • LEI54930089H3HF4C32SK783
  • StatusActive3
  • LEI statusLapsed (not renewed)3
  • Registered addressC/O The Corporation Trust Company, 19801 Wilmington, United States3
  • Registered withDivision of Corporations, Department of State, 41572813

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

-299.8%Operating margin5
-304.3%Net margin5
679.6%Revenue growth, 20215
-127.1%Return on equity5
0.88×Debt to equity5
-$185.4MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Cost of revenue3¢$4.8M
  • Selling, general and admin97¢$148.5M
  • Income tax0¢$105.0K

Out of $74.7M in revenue.5 The company lost money this year.

Financial statements

Revenue6785$74.7M in 2021+175% since 2015
0$20.0M$40.0M$60.0M$80.0M2015: $27.2M$27.2M20152016: $28.9M$28.9M2016+6%2017: $9.8M$9.8M2017−66%2018: $0$020182019: $3.6M$3.6M20192020: $9.6M$9.6M2020+163%2021: $74.7M$74.7M2021+680%
Operating income69785-$224.1M in 2021+370% since 2015
-$600.0M-$400.0M-$200.0M02015: -$47.7M-$47.7M20152016: -$72.7M-$72.7M2016+52%2017: -$119.9M-$119.9M2017+65%2018: -$141.2M-$141.2M2018+18%2019: -$429.8M-$429.8M2019+204%2020: -$247.7M-$247.7M2020−42%2021: -$224.1M-$224.1M2021−10%
Net income69785-$227.4M in 2021
-$600.0M-$400.0M-$200.0M0$200.0M2015: $26.1M$26.1M20152016: -$69.7M-$69.7M20162017: -$126.8M-$126.8M2017+82%2018: -$123.9M-$123.9M2018−2%2019: -$419.5M-$419.5M2019+239%2020: -$209.4M-$209.4M2020−50%2021: -$227.4M-$227.4M2021+9%
Fiscal year2015201620172018201920202021
Revenue$27.2M6$28.9M6$9.8M7$08$3.6M5$9.6M5$74.7M5
Cost of revenue$010$010$10.7M7$08$05$542.0K5$4.8M5
Research and development$27.9M6$41.8M9$67.4M9$08$251.4M5$10.7M5$05
Selling, general and admin$26.3M6$27.0M9$25.9M7$39.0M8$60.8M5$99.6M5$148.5M5
Operating income-$47.7M6-$72.7M9-$119.9M7-$141.2M8-$429.8M5-$247.7M5-$224.1M5
Interest
Income before tax-$227.3M5
Income tax-$15.9M6-$948.0K9$07$08$05-$17.4M5$105.0K5
Net income$26.1M6-$69.7M9-$126.8M7-$123.9M8-$419.5M5-$209.4M5-$227.4M5
Earnings per share$1.226-$2.816-$4.656-$9.745-$3.905-$4.075
Earnings per share (diluted)$1.226-$2.816-$4.656-$9.745-$3.905-$4.075
Shares (weighted, basic)55.9M shares5
Shares (weighted, diluted)55.9M shares5

Compare Zogenix (United States) with another company

Corporate structure

Zogenix (United States) sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Zogenix (United States)

  • RA CAPITAL MANAGEMENT, L.P. Filed SC 13G/A on Zogenix (United States), latest May 16, 2022 (2 filings since Feb 14, 2022)
  • Carlson Capital, L.P. Filed SC 13G on Zogenix (United States), latest Mar 14, 2022
  • CADIAN CAPITAL MANAGEMENT, LP Filed SC 13G/A on Zogenix (United States), latest Feb 14, 2022
  • Morgan Stanley Filed SC 13G/A on Zogenix (United States), latest Feb 11, 2022
  • VANGUARD GROUP INC Filed SC 13G/A on Zogenix (United States), latest Feb 10, 2022
  • Franklin Templeton Investments Filed SC 13G on Zogenix (United States), latest Feb 3, 2022
  • Zogenix (United States) San Diego, California, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Zogenix (United States) reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$11.4M5 Dec 31, 2021$11.5M5 Dec 31, 2020−1.4%
Accumulated depreciation$4.2M5 Dec 31, 2021$2.8M5 Dec 31, 2020+48.5%
Property and equipment, net$7.2M5 Dec 31, 2021$8.7M5 Dec 31, 2020−17.5%
Operating-lease assets (leased space)$6.6M5 Dec 31, 2021$7.7M5 Dec 31, 2020−14.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$101.2M5 Dec 31, 2021$166.9M5 Dec 31, 2020−39.4%
Marketable securities, current$200.5M5 Dec 31, 2021$338.2M5 Dec 31, 2020−40.7%
Debt securities available for sale$200.5M5 Dec 31, 2021$338.2M5 Dec 31, 2020−40.7%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$6.2M5 Dec 31, 2021$6.2M5 Dec 31, 20200%
Intangible assets, net (excluding goodwill)$90.7M5 Dec 31, 2021$98.6M5 Dec 31, 2020−8.0%
Indefinite-lived intangibles (excluding goodwill)$08 Dec 31, 2020$102.5M8 Dec 31, 2019−100.0%
Finite-lived intangibles, gross$102.5M5 Dec 31, 2021$102.5M5 Dec 31, 20200%
Accumulated amortization$11.8M5 Dec 31, 2021$3.9M5 Dec 31, 2020+200.0%
Finite-lived intangibles, net$90.7M5 Dec 31, 2021$98.6M8 Dec 31, 2020−8.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$5.5M5 Dec 31, 2021$1.0M5 Dec 31, 2020+435.3%
Raw materials$1.3M5 Dec 31, 2021$391.0K5 Dec 31, 2020+232.7%
Work in process$2.4M5 Dec 31, 2021$243.0K5 Dec 31, 2020+882.3%
Finished goods$1.8M5 Dec 31, 2021$392.0K5 Dec 31, 2020+360.2%

Leadership

Who has led Zogenix (United States), and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Roger Hawley2010–2015
  2. Stephen J. Farr2015–2022

President

  1. Stephen J. Farr2010–2022

Chief financial officer

  1. Ann D. Rhoads2010–2016

Chief operating officer

  1. Stephen J. Farr2010–2015
  2. Ashish M. Sagrolikar2021–2022
2010201520202025
Board members and other officers (22)

Former names

  • ZOGENIX INCSep 8, 2006 to Jul 14, 20104

Timeline

  1. Mar 7, 20228-K Entered a material agreement; Completed an acquisition or sale; Listing notice or transfer37
  2. Feb 28, 20228-K Results of operations38
  3. Feb 24, 20228-K Executive or director change39
  4. Jan 19, 20228-K Entered a material agreement; Regulation FD disclosure40
  5. Dec 2, 20218-K Other events41
  6. Nov 4, 20218-K Results of operations42
  7. May 14, 2015New chief executive Stephen J. Farr becomes CEO12
  8. Nov 22, 2010New chief executive Roger Hawley becomes CEO13
  9. 2006Founded Founded1

Calendar

When it reported results

  1. Feb 28, 2022Reported quarterly or annual results38
  2. Nov 4, 2021Reported quarterly or annual results42

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

56 filings to the SEC since October 2021: 2 annual reports, 1 quarterly reports, 6 major events, 18 insider forms, 7 large holders, 22 other. The latest 20:

  1. May 16, 2022SC 13G/A EDGAR
  2. Mar 17, 202215-12B EDGAR
  3. Mar 14, 2022SC 13G EDGAR
  4. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  5. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  6. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  7. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  8. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  9. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  10. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  11. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  12. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  13. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  14. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  15. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  16. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  17. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  18. Mar 9, 20224 FORM 4 SUBMISSION EDGAR
  19. Mar 7, 2022EFFECT EDGAR
  20. Mar 7, 2022EFFECT EDGAR

The 56 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

3 open-market trades by officers, directors and large owners since October 2021: 0 buys and 3 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Feb 1, 2022MAST ERLE TDirectorSale1,250$26.04$32.5KForm 4
Jan 19, 2022MAST ERLE TDirectorSale15,000$26.09$391.4KForm 4
Nov 29, 2021TANNENBAUM RENEE PDirectorSale5,305$11.72$62.2KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Zogenix (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARZOGENIX, INC.2
  • CIK0001375151
  • Employer ID (EIN)20-53007802
  • Filer statusLarge accelerated filer2
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)2834 Pharmaceutical Preparations2
  • Business address5959 Horton Street, Suite 500, Emeryville, CA 946082
  • Phone(510) 550-83002
  • Shares outstanding56,228,303 as of Feb 28, 202249
  • Public float$863.0M as of Jun 30, 202149
  • On EDGAR sinceSep 8, 20062
  • Filings886 in all: 4 (296), 8-K (215), SC 13G/A (65), 3 (42), 10-Q (33), SC 13G (31), CT ORDER (19), 424B5 (15)2
    All 52 form types

    10-K (12), CORRESP (11), DEF 14A (11), DEFA14A (11), EFFECT (9), UPLOAD (9), S-1/A (8), S-8 (7), S-8 POS (7), SC 14D9/A (7), 4/A (5), D (5), PRE 14A (5), S-3 (5), 8-K/A (4), 10-K/A (3), 144 (3), REGDEX (3), S-1 (3), SC 13D (3), SC 13D/A (3), SC TO-C (3), SC TO-T/A (3), SD (3), 424B4 (2), ARS (2), POS AM (2), REGDEX/A (2), S-3ASR (2), SC14D9C (2), SEC STAFF LETTER (2), 10-Q/A (1), 15-12B (1), 25-NSE (1), 424B3 (1), 8-A12B (1), CERTNAS (1), D/A (1), FWP (1), POS EX (1), RW (1), S-3MEF (1), SC 14D9 (1), SC TO-T (1)

  • Latest filingsAnnual report (10-K) Mar 1, 2022
    Quarterly report (10-Q) Nov 8, 2021
    Proxy statement (DEF 14A) Apr 15, 2021
    Latest 8-K (8-K) Mar 7, 2022

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
    SEC EDGAROther events
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49